Readystate Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,749
| Closed | -$444K | – | 402 |
|
|
2024
Q4 | $444K | Buy |
6,749
+1,495
| +28% | +$98.3K | 0.01% | 302 |
|
|
2024
Q3 | $369K | Sell |
5,254
-5,657
| -52% | -$398K | 0.01% | 253 |
|
|
2024
Q2 | $898K | Sell |
10,911
-1,815
| -14% | -$149K | 0.03% | 152 |
|
|
2024
Q1 | $1.11M | Hold |
12,726
| – | – | 0.02% | 174 |
|
|
2023
Q4 | $1.23M | Sell |
12,726
-3,674
| -22% | -$354K | 0.04% | 144 |
|
|
2023
Q3 | $1.45M | Buy |
+16,400
| New | +$1.45M | 0.07% | 112 |
|
|
2023
Q1 | – | Sell |
-8,419
| Closed | -$871K | – | 132 |
|
|
2022
Q4 | $871K | Buy |
+8,419
| New | +$871K | 0.21% | 53 |
|